NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Antimullerian Hormone in Endometriomas

CompletedN/A

Sponsor: Hospital Universitari de Bellvitge

Conditions: Endometriomas

Interventions: Surgical technique, Alcohol sclerotherapy

Countries: Spain

The purpose of this multicenter study is to evaluate the ovarian reserve after alcohol sclerotherapy of endometriomas versus conventional surgery.

Eligibility overview

Sex: FEMALE

Age: 18 Years to 40 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Women
* Age ≥18 and \<40 years
* Unilocular endometrioma according ultrasounds
* Endometrioma size: 35-100 mm during \> 3 months from diagnosis
* CA125 \<200 IU/mL and HE4 \< 70,
* AMH previous surgery between 1.2-4 ng/mL

Exclusion Criteria:

* Previous ovarian surgery or gynecological cancer
* Severe extraovarian endometriosis
* Dermoid or high risk of malignancy cysts
* Hormonal treatment 3 months before
* Pregnancy
* Mental disability

Locations (1)

L'Hospitalet de Llobregat, Barcelona, Spain